Dr. Reddy’s Laboratories secures key European endorsement for Rituximab biosimilar

Pallavi Madhiraju- July 30, 2024 0

In a significant development for the pharmaceutical industry, Dr. Reddy’s Laboratories Ltd. has received a positive opinion from the European Medicines Agency’s (EMA) Committee for ... Read More

FDA accepts review of Dr. Reddy’s biosimilar rituximab candidate, DRL_RI

Pallavi Madhiraju- July 12, 2023 0

Dr. Reddy's Laboratories, an Indian pharmaceutical company, announced that the US Food and Drug Administration (FDA) has accepted its Biologics License Application (BLA) for a ... Read More

Dr. Reddy’s Tocilizumab biosimilar shows promising results in phase 1 trial

Pallavi Madhiraju- June 5, 2023 0

Dr. Reddy's Laboratories, an Indian pharmaceutical company, announced a significant milestone as its tocilizumab biosimilar candidate, DRL_TC, successfully met primary and secondary endpoints in a ... Read More

BeiGene gets Brukinsa FDA approval for chronic lymphocytic leukemia

Raghuram Kadari- January 21, 2023 0

BeiGene has secured the approval of the US Food and Drug Administration (FDA) for the company’s Brukinsa (zanubrutinib) for the treatment of adult patients with ... Read More

Ipsen to acquire American biopharma company Epizyme for $247m

pallavi123- June 27, 2022 0

French pharma company Ipsen has agreed to acquire Epizyme, a Massachusetts-based commercial-stage biopharma company for an initial consideration of $247 million. Epizyme, which is listed ... Read More

Chronos-3 trial results : Aliqopa, rituximab combo meets primary endpoint of PFS, says Bayer

pallavi123- April 11, 2021 0

Chronos-3 trial results : Bayer said that the investigational combination of Aliqopa (copanlisib) and rituximab considerably increased progression-free survival (PFS) in patients having relapsed indolent ... Read More

Amgen, Allergan file BLA to FDA for Rituxan biosimilar ABP 798

pharmanewsdaily- December 20, 2019 0

Rituxan biosimilar ABP 798 : US biopharma company Amgen and Irish pharma company Allergan have submitted a Biologics License Application (BLA) to the US Food ... Read More

Pixuvri EMA approval : Servier NHL drug secures standard marketing authorization in Europe

pharmanewsdaily- June 13, 2019 0

Pixuvri EMA approval : French pharma company Servier has secured full approval for Pixuvri (pixantrone) from the European Commission (EC) as monotherapy for aggressive non-Hodgkin ... Read More

Nordic Nanovector begins Phase 1b trial of Betalutin and Rituximab combo for follicular lymphoma

pharmanewsdaily- November 4, 2018 0

Nordic Nanovector has commenced the dosing of the first patient in its Phase 1b clinical trial, dubbed Archer-1, which aims to evaluate the combination of ... Read More

Janssen Pharmaceutical’s IMBRUVICA and Rituximab combo wins FDA approval for waldenström’s macroglobulinemia treatment

pharmanewsdaily- August 27, 2018 0

Janssen Pharmaceutical, a subsidiary of Johnson & Johnson, has received approval from the US Food and Drug Administration (FDA) for its combination treatment of IMBRUVICA ... Read More